Loading...
RedHill Biopharma Ltd.
RDHL•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$2.17
$-0.18(-7.66%)
RedHill Biopharma Ltd. (RDHL) Financial Performance & Statements
Review RedHill Biopharma Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
23.49%
↑ 23.49%
Operating Income Growth
-215.68%
↓ 215.68%
Net Income Growth
-134.57%
↓ 134.57%
Operating Cash Flow Growth
73.84%
↑ 73.84%
Operating Margin
-181.69%
↓ 181.69%
Gross Margin
60.31%
↑ 60.31%
Net Profit Margin
-102.80%
↓ 102.80%
ROE
357.77%
↑ 357.77%
ROIC
349.59%
↑ 349.59%
RedHill Biopharma Ltd. (RDHL) Financial Statements
Explore quarterly and annual reports for RedHill Biopharma Ltd. stock.
| Metric | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $1.80M | $3.60M | $12.80M | $17.55M |
| Cost of Revenue | $806000.00 | $1.61M | $8.60M | $9.45M |
| Gross Profit | $990000.00 | $1.99M | $4.20M | $8.10M |
| Gross Profit Ratio | $0.55 | $0.55 | $0.33 | $0.46 |
| R&D Expenses | $1.25M | $1.08M | $1.13M | $1.61M |
| SG&A Expenses | $8.06M | $10.91M | $13.02M | $13.60M |
| Operating Expenses | $5.40M | -$27.09M | $14.15M | $15.21M |
| Total Costs & Expenses | $6.20M | -$25.48M | $22.75M | $24.66M |
| Interest Income | $7.01M | $21.58M | $11.27M | $3.19M |
| Interest Expense | $1.93M | $421000.00 | $0.00 | $31.78M |
| Depreciation & Amortization | $1.11M | $455694.00 | $2.003M | $2.08M |
| EBITDA | $2.69M | $50.64M | $757971.00 | -$1.81M |
| EBITDA Ratio | $1.50 | $30.88 | -$0.02 | -$0.10 |
| Operating Income | -$4.41M | $50.66M | -$9.95M | -$7.11M |
| Operating Income Ratio | -$2.45 | $14.08 | -$0.78 | -$0.40 |
| Other Income/Expenses (Net) | $5.17M | -$421000.00 | $6.22M | -$28.59M |
| Income Before Tax | $761000.00 | $50.24M | -$3.73M | -$35.70M |
| Income Before Tax Ratio | $0.42 | $13.96 | -$0.29 | -$2.03 |
| Income Tax Expense | $0.00 | $421000.00 | -$6.22M | $28.59M |
| Net Income | $761000.00 | $50.24M | $2.49M | -$64.29M |
| Net Income Ratio | $0.42 | $13.96 | $0.19 | -$3.66 |
| EPS | $0.24 | $20.44 | $1.07 | -$40.29 |
| Diluted EPS | $0.24 | $20.44 | $1.07 | -$40.29 |
| Weighted Avg Shares Outstanding | $3.19M | $2.44M | $2.33M | $1.60M |
| Weighted Avg Shares Outstanding (Diluted) | $3.19M | $2.44M | $2.33M | $1.60M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan